“…[1][2][3][4][5][6][7] Multiple studies have questioned the benefit of CPM because it does not improve survival in average-risk women [8][9][10][11][12][13] and may increase cost 14,15 and complications. 8,16,17 Numerous studies investigating the increasing use of CPM have identified significant factors related to patient, surgeon, and treatment facility. Patients undergoing CPM tend to be younger, 2-6 have a family history of breast cancer, 1,3 and carry a BRCA mutation.…”